Publications

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

Title

Author

Year

An interactive website tracking COVID-19 vaccine development.

Shrotri, M; SWINNEN, T; KAMPMANN, B; PARKER, EP K;

2021

LANCET GLOBAL HEALTH, (2021).9 5 10.1016/S2214-109X(21)00043-7.

Vasan, SK; JOBE, M; Mathews, J; Cole, F; Rathore, S; Jarjou, O; Thompson, D; Jarde, A; Bittaye, M; Ulijaszek, S; Fall, C; Osmond, C; PRENTICE, A; Karpe, F;

2021

BMJ open, (2021).11 2 10.1136/bmjopen-2020-042069.

Stillbirths, Neonatal Morbidity, and Mortality in Health-Facility Deliveries in Urban Gambia.

CAMARA, B; Oluwalana, C; Miyahara, R; Lush, A; KAMPMANN, B; Manneh, K; OKOMO, U; D'ALESSANDRO, U; ROCA, A;

2021

Frontiers in Pediatrics, (2021).9, 10.3389/fped.2021.579922.

Multipathogen Analysis of IgA and IgG Antigen Specificity for Selected Pathogens in Milk Produced by Women From Diverse Geographical Regions: The INSPIRE Study.

McGuire, MK; Randall, AZ; Seppo, AE; Järvinen, KM; Meehan, CL; Gindola, D; Williams, JE; Sellen, DW; Kamau-Mbuthia, EW; Kamundia, EW; Mbugua, S; Moore, SE; PRENTICE, AM; Foster, JA; Otoo, GE; Rodríguez, JM; Pareja, RG; Bode, L; McGuire, MA; Campo, JJ;

2021

Frontiers in immunology, (2021).11, 10.3389/fimmu.2020.614372.

Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca.

WHO SAGE Working Group on COVID-19 Vaccines,;

2021

, WHO (Geneva) (2021).

AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca: Background paper.

WHO SAGE Working Group on COVID-19 Vaccines,;

2021

, WO (Geneva) (2021).

Poor cardiovascular health is associated with subclinical atherosclerosis in apparently healthy sub-Saharan African populations: an H3Africa AWI-Gen study.

Nonterah, EA; Crowther, NJ; Oduro, A; Agongo, G; Micklesfield, LK; BOUA, PR; Choma, SS R; Mohamed, SF; Sorgho, H; Tollman, SM; Norris, SA; Raal, FJ; Grobbee, DE; Ramsay, M; Bots, ML; Klipstein-Grobusch, K; As part of the H3Africa AWI-Gen study,;

2021

BMC medicine, (2021).19 1 10.1186/s12916-021-01909-6.

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.

AFOLABI, MO; ISHOLA, D; MANNO, D; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; Baiden, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; GALLAGHER, KE; Gaddah, A; ... EBL3001 study group,

2021

Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00128-6.

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.

ISHOLA, D; MANNO, D; AFOLABI, MO; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; BAIDEN, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,

2021

Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00125-0.

Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history.

Coscolla, M; Gagneux, S; Menardo, F; Loiseau, C; Ruiz-Rodriguez, P; Borrell, S; Otchere, ID; Asante-Poku, A; Asare, P; Sánchez-Busó, L; Gehre, F; Sanoussi, CN; ANTONIO, M; Affolabi, D; Fyfe, J; Beckert, P; Niemann, S; Alabi, AS; Grobusch, MP; Kobbe, R; Parkhill, J; Beisel, C; Fenner, L; Böttger, EC; Meehan, CJ; ... Brites, D.

2021

Microbial genomics, (2021).7 2 10.1099/mgen.0.000477.